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Abstract
Objective
The eight-item Brief Illness Perception Questionnaire (B-IPQ) supposedly evaluates cogni-
tive and emotional representations of illness. This study examined the validity and reliability
of a traditional Chinese version of the B-IPQ in Hong Kong Chinese breast cancer survivors.
Methods
358 Chinese breast cancer survivors who had recently ended their primary treatment com-
pleted this B-IPQ Chinese version. Confirmatory factor analysis (CFA) tested the factor
structure. The internal consistency, construct, predictive and convergent validities of the
scale were assessed.
Results
CFA revealed that the original three-factor (cognitive-emotional representations and illness
comprehensibility) structure of the B-IPQ poorly fitted our sample. After deleting one item
measuring illness coherence, seven-item gave an optimal two-factor (cognitive-emotional
representations) structure for the B-IPQ (B-IPQ-7). Cronbach’s alpha for the two subscales
were 0.653 and 0.821, and for the overall seven-item scale of B-IPQ was 0.783. Correlations
of illness perception and physical symptom distress, anxiety, depression and known-group
comparison between different treatment status suggested acceptable construct validity.
The association between baseline illness perception and psychological distress at 3-month
follow up supported predictive validity.
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Conclusions
B-IPQ-7 appears to be a moderately valid measure of illness perception in cancer popula-
tion, potentially useful for assessing illness representations in Chinese women with breast
cancer.
Introduction
Individuals constructor elaborate illness representations involving both cognitive and emo-
tional elements when facing a health threat or illness [1]. Several core cognitive elements of ill-
ness representations have been proposed: consequences, timeline, control, identity, and causes
[2]. Consequences reflect anticipated or perceived effects or outcomes of illness on an individu-
al’s life. Timeline reflects elements of perceived disease duration. Identity captures elements
including concrete symptoms manifestations and abstract symptom conception and patient
beliefs about the illness characteristics. Control reflects patients’ beliefs about the extent that
they and/or treatment can control the disease. Causes reflect patients’ beliefs about why the ill-
ness developed. Additional emotional elements of representations include individual’s concern
about, and perceived emotional impact of their illness. These cognitive and emotional compo-
nents of illness representations were significantly associated with coping behaviors [3], psycho-
logical distress [4], and quality of life [5, 6] in previous studies of cancer patients.
The Illness Perception Questionnaire (IPQ) developed by Weinman et al. was the first mea-
sure of illness perception, assessing five components of cognitive representations of illness [7].
A revised version, the Illness Perception Questionnaire-Revised (IPQ-R) divided the dimen-
sion of control into personal control and treatment control, and extended the original IPQ by
adding more items and new subscales to assess cyclical timeline perception and emotional rep-
resentations, and illness coherence, a dimension considered to reflect meta-cognition which
was not part of the original formulation [8]. Although IPQ-R is more comprehensive, at
80-items it is lengthy, increasing both response burden and potentially greater non-response
and attrition. The Brief Illness Perception Questionnaire (B-IPQ) is a respondent-friendly ver-
sion that uses the single item that loads highest on each IPQ-R dimension. The original English
version of B-IPQ demonstrated good test-retest reliability, and satisfactory concurrent, predic-
tive and discriminant validity [9].
The B-IPQ has been translated into, and validated in different languages. For instance, the
Spanish version of B-IPQ was found to be linguistically and conceptually comparable to the
original English version [10]. The validation study of Dutch version confirmed its face and
content validity, but reported poor test-retest reliability [11]. Using an Iranian diabetic sample,
Bazzazian et al. [12] reported a low internal consistency (Cronbach’s alpha = 0.53) of B-IPQ in
contrast to a Polish version with more satisfactory internal consistency of α = 0.74 [13]. A Chi-
nese version of the B-IPQ showed acceptable test-retest reliability, internal consistency, and
construct and discriminant validity in patients with Coronary Heart Disease [14]. Although
the original English and translated versions of the B-IPQ had been validated in patients with
various chronic illnesses, cancer has not yet been included. Moreover, most studies on cancer-
related illness perception were done in Western population. Since cancer patients show cul-
tural and ethnically-attributable variation in cancer perception [15] to pursue studies of cancer
in other ethnicities a culturally-valid B-IPQ is required. Furthermore, existing B-IPQ valida-
tion studies primarily assessed only the internal consistency and the construct validity. To our
knowledge, no study has tested B-IPQ factorial validity. Conceptually, the eight-item B-IPQ
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captures three aspects of illness perception: cognitive (5 items) and emotional (2 items) dimen-
sions of illness representations and illness coherence (1 item). There is no consensus in the
literature whether B-IPQ scores should be interpreted as eight items on three subscales (cogni-
tive and emotional components of illness representations and illness comprehensibility) [16,
17] or as seven items with two subscales (cognitive and emotional components of representa-
tions) [18].
To address this literature gap, we examined the psychometric properties of Chinese version
of the B-IPQ in a Hong Kong Chinese sample of breast cancer survivors. Specifically, we evalu-
ated data fit for the eight-item three-factor model and the seven-item two-factor model the lat-
ter minus the ‘illness coherence’ item. We also tested the internal consistency, construct and
predictive validity of the B-IPQ.
Methods
Sample size calculation
There is no consensus on how best to compute a priori the sample size used to validate a scale
[19]. Since the present study used confirmatory factorial analysis (CFA) and maximum likeli-
hood (ML) as the estimation model, the N:q rule (N: cases; q: number of parameters that
require statistical estimates) was chosen to calculate the sample size [20]. In this study, q = 26,
and an N:q ration of 10: 1 was specified. Thus, the minimum sample size required for our
study is 260. To avoid loss of power due to expected drop-out between baseline and 3-month
follow-up we increased the targeted sample by ~one third.
Sample and settings
Following Ethics Committee approval from the University of Hong Kong and Hospital
Authority, and as part of a larger ongoing study of over 1,000 women attending five govern-
ment-funded oncology outpatient clinics and having a known diagnosis of breast cancer who
were consecutively recruited between 2010-2013 the first 383 were enrolled for the present
study. The inclusion criteria were age> = 18 years, no longer than 6 months since completion
of primary treatment (surgery, cytotoxic chemotherapy and radiotherapy), and Cantonese/
Mandarin-speaking. Exclusion criteria were linguistic or intellectual incapacity or age over 85
years. Each woman was approached while awaiting their consultation in the out-patient clinic
by one of a team of trained research assistants. Written informed consent was obtained from
all participants after explanation of the study. Face-to-face questionnaire-based interview was
conducted immediately thereafter. Participants were asked to complete a follow-up interview
at 3 months post-baseline.
Measures
Illness perception. Illness perception was assessed by the Chinese version of Brief Illness
Perception Questionnaire (B-IPQ) [21]. The B-IPQ includes nine items, covering three
aspects: cognitive dimensions of illness representations (cognitive representation), emotional
dimensions of illness representations (emotional representation), and illness comprehensibil-
ity [9]. Cognitive representation is assessed by five items addressing consequences (Item 1),
timeline (Item 2), personal control (Item 3), treatment control (Item 4), and identity (Item 5);
emotional aspects of illness representations are assessed by two items addressing concern
(Item 6) and emotional impact (Item 8). Illness comprehensibility is assessed by one item:
coherence (Item 7). All items are scored on an 11-point Likert scale (range: 0-10), with higher
scores indicating more cognitive or emotional illness representations. The casual dimension,
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which being an open-ended question (Item 9), involves patients identifying their three most
important perceived causes of breast cancer. Because of this qualitative nature the Casual
dimension of representation was excluded from the present study. The Chinese version of the
B-IPQ required approximately 5 minutes to complete.
Comparative measures
Physical symptom distress. Physical symptom distress was measured by the Physical
Symptom Distress subscale (PHYS) of the validated Chinese version of the Memorial Symp-
tom Assessment Scale Short-Form (MSAS-SF) [22]. This requires patients to indicate if they
had experienced any of the listed symptoms over the past 1 week and, if so, rate the intensity of
distress caused by each symptom on a five-point Likert scale ranging from 0 “Not at all” to 4
“Very much”. The Chinese version of MSAS-SF has good psychometrics, including internal
consistency (Cronbach’s α: 0.84-0.91) [22].
Psychological distress. Psychological distress was examined by the 14-item Chinese ver-
sion of Hospital Anxiety and Depression Scale (HADS) [23], which uses a four-point (0-3)
Likert scale to assess responses to two 7-item subscales that assess anxiety (HADS-Anxiety)
and depression (HADS-Depression) respectively. The possible range of scores for each sub-
scale is 0-21, with higher scores indicating greater level of anxiety or depression. The Chinese
version of both subscales HADS-Anxiety (Cronbach’s α = 0.86) and HADS-Depression (Cron-
bach’s α = 0.82) demonstrate good psychometrics [23].
All measures were administered at baseline, except for the HADS-Anxiety and HADS-De-
pression, which were assessed at both baseline and 3 months post-baseline.
Socio-demographic data including age, marital status, education level, occupation, and
family income were also collected during the interview. Medical data were collected from med-
ical records.
Statistical analysis
Descriptive statistics summarized participants’ socio-demographic and clinical characteristics.
To assess the factorial validity of B-IPQ, confirmatory factor analysis (CFA) was performed
using Mplus version 6 software. Since the B-IPQ scores can be used as an item total or individ-
ually as domain scores to assess illness perception, we compared both hierarchical and corre-
lated models of the B-IPQ to determine which gave the best data fit. We used multiple fit
indices to evaluate model-data fit, including Chi-squared statistic, root mean square error of
approximation (RMSEA) with 90% confidence interval, standardized root mean square resid-
ual (SRMR), comparative fit indices (CFI) and Tucker Lewis Index (TLI). RMSEA values
0.10 with 90% confidence interval, SRMR values0.080, CFI and TLI values 0.90 suggest
acceptable model fit [24]. Exploratory factor analysis (EFA) was conducted if both the eight-
item three-factor (cognitive and emotional illness representations and illness comprehensibil-
ity) and seven-item two-factor (cognitive and emotional illness representations) model were
not supported, followed by CFA to verify the revised factorial structure.
Cronbach’s alpha coefficient was used to examine the scale’s internal consistency with the
minimal acceptable alpha values of 0.7 [25, 26]. Construct validity was assessed by correlating
B-IPQ scores with physical symptom distress (MSAS-PHYS) and psychological distress
(HADS-Anxiety and HADS-Depression) scores. We hypothesized that the B-IPQ would cor-
relate with greater physical symptom distress and psychological distress [27]. All correlation
was performed by Pearson’s correlation analysis. We also assessed construct validity using a
known-group comparison approach (previously had chemotherapy vs. previously did not
require chemotherapy). The need for chemotherapy could indicate earlier vs. later disease
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status. We hypothesized that patients having had chemotherapy were likely to report more nega-
tive illness perception than those without chemotherapy. Student’s t-test was used to test the
hypothesis. Predictive validity was assessed using multivariate regression to examine the relation-
ship between baseline illness perception and psychological distress at 3-month follow-up. We
hypothesized that patients with more negative illness perception at baseline would report a higher
level of psychological distress at 3-month follow-up. Apart from CFA, all data analyses were con-
ducted using Statistical Package for Social Sciences version 20.0 (SPSS, Chicago, IL, USA).
Result
Sample characteristics
Of 383 eligible breast cancer survivors approached 358 (93.5%) provided full informed consent
and completed all the baseline questionnaires, and 286 (79.9%) finished 3-month follow-up
assessment. Socio-demographic and clinical characteristics are summarized in Table 1. Pa-
tients’ mean age was 51.4 years (SD = 9.7, range = 24-87). Most participants (70.7%) were
married, 75.1% had secondary or above education achievement, and 43% were currently
employed. The majority (78.0%) were diagnosed with early stage breast cancer. Average dura-
tion of time since diagnosis was 10.9 months (SD = 10.6). Almost all participants had surgery
as primary treatment, 78.5% adjuvant chemotherapy, and 84.9% adjuvant radiation therapy.
Factorial validity
Firstly, hierarchical and correlated CFA models were performed on the sample separately to
test the eight-item three-factor (cognitive, emotional representation and illness comprehensi-
bility) fit. Then, further hierarchical and correlated CFA models were run on the same sample
to test the seven-item (missing the illness coherence item 7), two-factor(cognitive and emo-
tional representations) formulation fit. The goodness-of-fit indices of all the four models are
summarized in Table 2. Both eight-item models failed to meet minimum fit criteria. In con-
trast, the seven-item two-factor hierarchical and correlated models revealed a good fit to the
data (SRMR values0.080, RMSEA values0.10, CFI, and TLI all>0.90; Table 2). Because
the seven-item (without item 7) two-factor hierarchical model and correlated model were
nested, we used Likelihood Ratio Tests (LRT) to compare chi-squared difference. Results indi-
cated that there was no statistically significant difference between the two models in explaining
the data (Δ χ2 (1) = 0, P>0.05), therefore, the correlated model was preferred on the basis of
model parsimony having more degrees of freedom. Hence, hereafter the subsequent reliability
and validity assessment is based on the seven-item two-factor correlated model (B-IPQ-7).
Reliability
Cronbach’s alpha for the overall scale of B-IPQ-7 was 0.783, indicating acceptable internal
consistency. While the ‘emotional illness representations’ subscale demonstrated good internal
consistency (Cronbach’s α = 0.821), the ‘cognitive illness representations’ subscale showed
only borderline-fair internal consistency (Cronbach’s α = 0.653) but the latter comprised the
majority of items. This result is not unexpected given the five cognitive items were developed
originally to assess different dimensions, and so they may not “scale” well.
Construct validity
The two B-IPQ-7 subscale scores demonstrated, as expected, moderate positive correlations
with physical symptom distress (correlation coefficients (r) ranged from 0.392 to 0.442), anxi-
ety (r ranged from 0.422 to 0.552) and depression (r ranged from 0.429 to 0.494) scores
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(Table 3). Student’s t-tests were used to test known-group comparison (chemotherapy vs. no
chemotherapy). Patient who had received chemotherapy reported significantly higher scores
on the “cognitive illness representations” subscale (p = 0.016) (Table 4).
Predictive validity
After controlling for socio-demographic and clinical characteristics, both baseline cognitive
representation subscale and emotional representation subscale predicted higher HADS anxiety
(β = 0.144, p<0.05; β = 0.405, p<0.001, respectively) and HADS depression (β = 0.117, p<0.05;
β = 0.347, p<0.001, respectively) scores at 3-month follow up (Table 5).
Table 1. Socio-demographic and clinical characteristics of the participants.
Variables n = 358
Age (years) Mean (SD) 51.36 (9.65)
Marital status
Single 55 (15.4%)
Married/cohabited 253 (70.7%)
Divorced/separated 22 (6.1%)
Widowed 28 (7.8%)
Education level
No formal/primary 89 (24.9%)
Secondary 196 (54.7%)
Tertiary 73 (20.4%)
Occupation
Employed 153 (42.7%)
Retired 46 (12.8%)
Housewife 70 (19.6%)
Unemployed 89 (24.9%)
Monthly family income (HK$)*
< = 10,000 78 (21.8%)
10,001-20,000 88 (24.6%)
20,001-30,000 59 (16.5%)
>30,000 108 (30.2%)
Missing 25 (7.0%)
Stage of disease
0/I 117 (32.7%)
II 162 (45.3%)
III/IV 75 (20.9%)
Missing 4 (1.1%)
Time since diagnosis(months) Mean (SD) 10.92 (10.56)
Type of surgery
Breast conserving therapy 151 (42.2%)
Mastectomy 179 (50.0%)
Mastectomy and breast reconstruction 24 (6.7%)
Missing 4 (1.1%)
Had chemotherapy 281 (78.5%)
Had radiation therapy 304 (84.9%)
Currently receiving hormonal therapy 226 (63.1%)
* 1US$ = 7.8 HK$
https://doi.org/10.1371/journal.pone.0174093.t001
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Discussion
This study assessed the factorial validity, construct validity, and reliability of the Chinese ver-
sion of the B-IPQ in Hong Kong Chinese breast cancer survivors. Confirmatory factor analysis
revealed that the eight-item, three-factor model did not show adequate fit to the data of our
sample. In contrast, the seven-item two-factor model showed acceptable fit to the data. This is
consistent with Leventhal’s common sense model in which illness perception involves both
cognitive and emotional dimensions of illness representations. The deleted item 7 (illness
coherence) asked “how well do you feel you understand your illness?”, measuring to what
extent individuals’ illness perception reflected a logical and consistent understanding of their
illness [8]. This “thoughts about your thinking” is termed meta-cognition [28]. Therefore, it
was not surprising that the seven-item two-factor model, omitting this meta-cognition item 7,
showed better data fit than did the eight-item, three-factor model. Furthermore, data indicated
that the two-factor correlated model was the more parsimonious model in explaining the data.
Consequently, ‘cognitive illness representations’ subscale and ‘emotional illness representa-
tions’ subscale were confirmed, and two composite scores of the seven-item B-IPQ appear to
be most applicable.
The Chinese version of the two-factor B-IPQ-7 showed good internal consistency for both
of the overall scale, as well as the ‘emotional illness representations’ subscale. The ‘cognitive ill-
ness representations’ subscale, however, demonstrated only marginally acceptable internal
consistency. Post hoc examination of the data showed item 3 (personal control) had the lowest
item-total correlation (r = 0.290) but deleting this item only marginally increased the ‘cognitive
illness representations’ subscale Cronbach’s alpha from 0.653 to 0.659. However, to be consis-
tent with the original theoretical model item 3 was retained. The low alpha suggests that scal-
ability may not be particularly reliable for the cognition items. Possible, the instrument is too
“brief” and might benefit from the addition of one more item each to the cognitive dimen-
sions. The Chinese version of B-IPQ-7 showed good construct validity indicated by positive
correlations with the measures of physical symptom distress, anxiety and depression.
Table 2. Goodness-of-fit indices of confirmatory factor analyses of the B-IPQ.
Model χ2 df P-value CFI TLI AIC SRMR RMSEA(90% CI)
Eight-item B-IPQ
Three-factor hierarchical model 184.681 19 <0.001 0.767 0.657 12784.150 0.137 0.156 (0.136, 0.177)
Three-factor correlated model 91.547 18 <0.001 0.897 0.839 12875.285 0.072 0.107 (0.086, 0.129)
Seven-item B-IPQ (without IP7)
Two-factor Hierarchical model 50.808 13 <0.001 0.944 0.910 5684.718 0.056 0.090 (0.065, 0.117)
Two-factor correlated model 50.808 14 <0.001 0.945 0.918 5684.718 0.056 0.086 (0.061, 0.112)
B-IPQ, Brief Illness Perception Questionnaire
χ2: Chi-Square statistic; CFI: Comparative Fit Index; TLI: Tucker Lewis Index; AIC: Akaike Information Criterion; RMSEA: Root Mean Square Error of
Approximation; SRMR: Standardized Root Mean-Square Residual.
https://doi.org/10.1371/journal.pone.0174093.t002
Table 3. Correlation matrix for convergent and divergent validity.
‘Cognitive illness representations’ subscale ‘Emotional illness representations’ subscale
Physical symptom distress at baseline 0.392** 0.415**
Anxiety at baseline 0.422** 0.552**
Depression at baseline 0.429** 0.481**
P<0.01**
https://doi.org/10.1371/journal.pone.0174093.t003
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The Chinese version of the B-IPQ-7 demonstrated expected patterns for known-group
comparison in terms of treatment status, supporting its clinical validity. Our findings showed
that women who had previously received chemotherapy reported greater cognitive illness rep-
resentations. The Chinese version of B-IPQ-7 also showed good predictive validity in our sam-
ple of breast cancer survivors. Adjusting for socio-demographic and clinical characteristics,
baseline cognitive illness representations and emotional illness representations subscales sig-
nificantly predicted anxiety and distress at 3-month follow up.
In summary, our study suggested that the seven-item, two-factor (cognitive and emotional
illness representations) Chinese version of B-IPQ (B-IPQ-7) was the best fitting measurement
model in Chinese breast cancer survivors, therefore, its use in future studies of two composite
scores is supported. This two-factor Chinese version of the B-IPQ-7 demonstrated acceptable
validity and reliability for assessing illness perceptions of breast cancer. While a strength of the
Table 4. Known-groups comparisons of B-IPQ mean scores (S.D.) by chemotherapy.
Chemotherapy P-value
Yes No
‘Cognitive illness representations’ subscale 21.64 (8.71) 18.88 (8.69) 0.016
‘Emotional illness representations’ subscale 9.16 (5.23) 8.49 (5.21) 0.316
https://doi.org/10.1371/journal.pone.0174093.t004
Table 5. Standardized betas of multivariate linear regression analyses evaluating the association of B-IPQ-7 with 3-month psychological anxiety
and depression.
Anxiety at 3-month follow up Depression at 3-month follow up
Age - -
Education level
Primary or below Referent Referent
Secondary or above - -
Occupation
Employed Referent Referent
Not employed - -
Total monthly household income (HK$)
Below 10,000 Referent Referent
10,001-20,000 - -
20,001-30,000 - -
More than 30,000 - -
Time since first diagnosis - -
Family history 0.115* 0.117*
Surgery - -
Chemotherapy - -
Radiation therapy - -
‘Cognitive illness representations’ subscale 0.144* 0.117 *
‘Emotional illness representations’ subscale 0.405*** 0.347***
R2 0.268 0.242
*P<0.05
***P<0.001
Dash sign (-) means variables that were excluded by the stepwise multivariate linear regression model.
The italic values are R2.
Variables were excluded and retained with p-values (entry) = 0.05 and (removal) = 0.1.
https://doi.org/10.1371/journal.pone.0174093.t005
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present study was the adoption of a longitudinal design, allowing assessment of predictive
validity, our study sample is limited to Hong Kong Chinese women diagnosed with breast can-
cer. Future studies should evaluate the psychometric properties of the Chinese version of
B-IPQ-7 for use among Chinese patients with other cancer types. Moreover, test-rest reliability
was not assessed in the present study. Consideration should be given to doubling the number
of items to improve scalability.
Supporting information
S1 Dataset. S1 Dataset for the manuscript.
(SAV)
Acknowledgments
The authors are grateful to all the research assistants for their contributions of the data collec-
tion and management, and to the cancer survivors who participated in the study.
Author Contributions
Conceptualization: WWTL RF NZ.
Data curation: WWTL RF.
Formal analysis: NZ.
Funding acquisition: WWTL RF.
Investigation: WWTL RF IS KKKC CL AN WKS JT VL.
Methodology: WWTL RF NZ.
Project administration: WWTL.
Resources: IS KKKC CL AN WKS JT VL.
Software: WWTL RF.
Supervision: WWTL RF.
Validation: WWTL RF.
Visualization: WWTL RF.
Writing – original draft: NZ.
Writing – review & editing: RF WWTL IS KKKC CL AN WKS JT VL.
References
1. Leventhal H, Nerenz D, Steele D. Illness representations and coping with health threats. In: Rachman
S, editor. Handbook of Psychology and Health. 4. Hillside, New Jersey: Erlbaum; 1984. p. 219–52.
2. Diefenbach MA, Leventhal H. The common-sense model of illness representation: Theoretical and
practical considerations. J Soc Distress Homel. 1996; 5(1):11–38.
3. Hopman P, Rijken M. Illness perceptions of cancer patients: relationships with illness characteristics
and coping. Psycho-Oncology. 2015; 24(1):11–8. https://doi.org/10.1002/pon.3591 PMID: 24891136
4. Gray NM, Hall SJ, Browne S, Johnston M, Lee AJ, Macleod U, et al. Predictors of anxiety and depres-
sion in people with colorectal cancer. Supportive Care in Cancer. 2014; 22(2):307–14. https://doi.org/
10.1007/s00520-013-1963-8 PMID: 24077745
Psychometric assessment of the Chinese version of B-IPQ in breast cancer survivors
PLOS ONE | https://doi.org/10.1371/journal.pone.0174093 March 20, 2017 9 / 10
5. Mickeviciene A, Vanagas G, Jievaltas M, Ulys A. Does Illness Perception Explain Quality of Life of
Patients With Prostate Cancer? Med Lith. 2013; 49(5):235–41.
6. Ashley L, Marti J, Jones H, Velikova G, Wright P. Illness perceptions within 6months of cancer diagnosis
are an independent prospective predictor of health-related quality of life 15months post-diagnosis. Psy-
cho-Oncology. 2015; 24(11):1463–70. https://doi.org/10.1002/pon.3812 PMID: 25946704
7. Weinman J, Petrie KJ, MossMorris R, Horne R. The illness perception questionnaire: A new method for
assessing the cognitive representation of illness. Psychology & Health. 1996; 11(3):431–45.
8. Moss-Morris R, Weinman J, Petrie K, Horne R, Cameron L, Buick D. The revised illness perception
questionnaire (IPQ-R). Psychology and health. 2002; 17(1):1–16.
9. Broadbent E, Petrie KJ, Main J, Weinman J. The Brief Illness Perception Questionnaire. J Psychosom
Res. 2006; 60(6):631–7. https://doi.org/10.1016/j.jpsychores.2005.10.020 PMID: 16731240
10. Pacheco-Huergo V, Viladrich C, Pujol-Ribera E, Cabezas-Pena C, Nunez M, Roura-Olmeda P, et al.
Perception in chronic illnesses: linguistic validation of the revised Illness Perception Questionnaire and
the Brief Illness Perception Questionnaire for a Spanish population. Aten Prim. 2012; 44(5):280–7.
11. de Raaij EJ, Schroder C, Maissan FJ, Pool JJ, Wittink H. Cross-cultural adaptation and measurement
properties of the Brief Illness Perception Questionnaire-Dutch Language Version. Manual therapy.
2012; 17(4):330–5. https://doi.org/10.1016/j.math.2012.03.001 PMID: 22483222
12. Bazzazian S, Besharat MA. An explanatory model of adjustment to type I diabetes based on attach-
ment, coping, and self-regulation theories. Psychology Health & Medicine. 2012; 17(1):47–58.
13. Nowicka-Sauer K, Banaszkiewicz D, Staskiewicz I, Kopczynski P, Hajduk A, Czuszynska Z, et al. Ill-
ness perception in Polish patients with chronic diseases: Psychometric properties of the Brief Illness
Perception Questionnaire. Journal of health psychology. 2015.
14. Lin YP, Chiu KM, Wang TJ. Reliability and validity of the Chinese version of the brief illness perception
questionnaire for patients with coronary heart disease. Journal of the Oriental Institute of Technology.
2011; 31:147–57.
15. Dein S. Explanatory models of and attitudes towards cancer in different cultures. Lancet Oncology.
2004; 5(2):119–24. https://doi.org/10.1016/S1470-2045(04)01386-5 PMID: 14761816
16. Sampaio R, Graca Pereira M, Winck JC. Obstructive sleep apnea representations, self-efficacy and
family coping regarding APAP adherence: a longitudinal study. Psychology, health & medicine. 2014;
19(1):59–69.
17. Thong MS, Kaptein AA, Vissers PA, Vreugdenhil G, van de Poll-Franse LV. Illness perceptions are
associated with mortality among 1552 colorectal cancer survivors: a study from the population-based
PROFILES registry. J Cancer Surviv. 2016.
18. Rizou I, De Gucht V, Papavasiliou A, Maes S. The contribution of illness perceptions to fatigue and
sleep problems in youngsters with epilepsy. European journal of paediatric neurology: EJPN: official
journal of the European Paediatric Neurology Society. 2016; 20(1):93–9.
19. Anthoine E, Moret L, Regnault A, Sebille V, Hardouin JB. Sample size used to validate a scale: a review
of publications on newly-developed patient reported outcomes measures. Health and quality of life out-
comes. 2014; 12:176. PubMed Central PMCID: PMCPMC4275948. https://doi.org/10.1186/s12955-
014-0176-2 PMID: 25492701
20. Kline RB. Principles and practice of structural equation modeling: Guilford publications; 2015.
21. Xue F, Lin Y. Brief illness perception questionnaire: Chinese version [cited 2010 01/08]. Available from:
http://www.uib.no/ipq/pdf/B-IPQ-Chinese.pdf.
22. Lam WWT, Law CC, Fu YT, Wong KH, Chang VT, Fielding R. New Insights in Symptom Assessment:
The Chinese Versions of the Memorial Symptom Assessment Scale Short Form (MSAS-SF) and the
Condensed MSAS (CMSAS). J Pain Symptom Manag. 2008; 36(6):584–95.
23. Leung CM, Wing YK, Kwong PK, Lo A, Shum K. Validation of the Chinese-Cantonese version of the
Hospital Anxiety and Depression Scale and comparison with the Hamilton Rating Scale of Depression.
Acta Psychiat Scand. 1999; 100(6):456–61. PMID: 10626925
24. Hair J, Black W, Babin B, Anderson R. Multivariate data analysis: Pearson new international edition.
Upper Saddle River: Pearson; 2013.
25. Cronbach LJ. Coefficient alpha and the internal structure of tests. psychometrika. 1951; 16(3):297–334.
26. Bland JM, Altman DG. Cronbach’s alpha. Bmj. 1997; 314(7080):572. PubMed Central PMCID:
PMC2126061. PMID: 9055718
27. Zhang N, Fielding R, Soong I, Chan KKK, Tsang J, Lee V, et al. Illness perceptions among cancer survi-
vors. Supportive Care in Cancer. 2016; 24(3):1295–304. https://doi.org/10.1007/s00520-015-2914-3
PMID: 26314704
28. Metcalfe JE, Shimamura AP. Metacognition: Knowing about knowing: The MIT Press; 1994.
Psychometric assessment of the Chinese version of B-IPQ in breast cancer survivors
PLOS ONE | https://doi.org/10.1371/journal.pone.0174093 March 20, 2017 10 / 10
